financetom
Business
financetom
/
Business
/
VEON's Q1 Earnings, Revenue Rise; Reiterates 2025 Revenue Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
VEON's Q1 Earnings, Revenue Rise; Reiterates 2025 Revenue Guidance
May 26, 2025 8:19 AM

03:55 AM EDT, 05/15/2025 (MT Newswires) -- VEON (VEON) reported Q1 earnings Thursday of $1.36 per diluted share, up from $0.79 a year earlier.

An analyst polled by FactSet expected $0.83.

Revenue for the quarter ended March 31 was $1.03 billion compared with $942 million a year earlier.

An analyst surveyed by FactSet expected $996 million.

The company maintained its 2025 total revenue growth guidance of between 12% and 14%. Four analysts surveyed by FactSet expect $4.22 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders
AbbVie, Gilgamesh Pharmaceuticals Partner to Develop Therapies for Psychiatric Disorders
May 13, 2024
09:34 AM EDT, 05/13/2024 (MT Newswires) -- AbbVie ( ABBV ) and Gilgamesh Pharmaceuticals said Monday that they have entered into an option-to-license agreement to develop neuroplastogens to treat psychiatric disorders. Development and commercialization activities will be led by AbbVie ( ABBV ) upon exercise of the option, according to the companies. Gilgamesh will get $65 million in upfront payment...
Update: Blackstone to Take Japan's I'rom Private at 50% Premium
Update: Blackstone to Take Japan's I'rom Private at 50% Premium
May 13, 2024
09:32 AM EDT, 05/13/2024 (MT Newswires) -- (Updates with additional information) Blackstone (BX) said Monday its private equity funds and vehicles have entered a definitive agreement with the management of Japanese pharmaceutical services company I'rom Group to take it private. The asset management firm will offer to acquire I'rom shares at 2,800 yen ($17.96) per share -- about a 50%...
Permian Resources Shareholders Launch Public Offering of 51.8 Million Class A Shares
Permian Resources Shareholders Launch Public Offering of 51.8 Million Class A Shares
May 13, 2024
09:31 AM EDT, 05/13/2024 (MT Newswires) -- Permian Resources ( PR ) said Monday that certain shareholders had launched a public offering of about 51.8 million of its Class A shares. The company said the sellers include certain affiliates of EnCap Investments, NGP Energy Capital Management, Pearl Energy Investments, Riverstone Investment Group, and a member of Permian's board. The oil...
Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program
Collegium Pharmaceutical Launches $35 Million Accelerated Share Repurchase Program
May 13, 2024
09:31 AM EDT, 05/13/2024 (MT Newswires) -- Collegium Pharmaceutical ( COLL ) said Monday that it has signed an accelerated share repurchase agreement with investment bank Jefferies to buy back $35 million of its common stock. Collegium said it will execute the deal as part of a $150 million share repurchase program the board authorized in January. Following the completion...
Copyright 2023-2026 - www.financetom.com All Rights Reserved